Perampanel offers meaningful seizure control and an acceptable safety profile for patients with brain tumor-related epilepsy, a new review shows.

Acoustic analysis of patient-clinician conversations offers a noninvasive way to screen for undiagnosed cognitive impairment in older adults.

FDA accepts the resubmitted NDA for SL1009 (sodium dichloroacetate) to treat pyruvate dehydrogenase complex deficiency.

Melatonin may offer modest pain relief and improved sleep for patients with chronic musculoskeletal pain, but it lacks benefit for postoperative pain.

Better cardiovascular health during pregnancy is associated with longer time to incident postdelivery diagnosis of cardiometabolic conditions.

Many adults born with a very low birth weight or very preterm exhibit lower positive functioning in early adulthood.

A 2026 guideline on the management of dyslipidemia expands recommendations for primary prevention statin therapy among the US population.

An emergency presentation for a cancer diagnosis is common and predicts persistently elevated mortality among older US adults.

Molecular profiling, biomarker detection, and in vivo imaging are reshaping how neurologists diagnose neurodegenerative ...

Older adults with traumatic brain injury may have an increased risk for neurologic conditions both before and after their injury.

The FDA has approved Simtriyo (centanafadine), a first-in-class NDSRI and CNS stimulant, for adult and pediatric ADHD aged 6 years and older.

Plasmapheresis is associated with improved outcomes among those who may not respond completely to steroids for treating MOGAD attacks.